|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 532.94 USD | +2.68% |
|
+1.35% | +9.38% |
| 08-06 | United Therapeutics Insider Sold Shares Worth $4,927,985, According to a Recent SEC Filing | MT |
| 08-06 | MannKind's Diversified Portfolio Seen Leading to Higher Revenue in H2, Wedbush Says | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bullish |
| Resistance | 535.83 | 596.76 | 588.38 |
| Spread/Res. | -0.54% | -10.69% | -9.42% |
| Spread/Supp. | +3.22% | +12.64% | +27.32% |
| Support | 516.31 | 473.12 | 418.58 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UTHR Stock
- Charts United Therapeutics Corporation
Select your edition
All financial news and data tailored to specific country editions
